Parkinson's drug shortage resolved early: supply resumes November

The main supplier of a key Parkinson's remedy has moved up production resumption from March to November, ending an anticipated multi-month shortage. The initial halt was announced without prior warning, causing concern among patients and clinicians. Early resumption reduces but does not eliminate risk of treatment gaps.